Orbimed Advisors Llc bought $15M of Scribe Therapeutics, Inc. (SCTX) stock

Orbimed Advisors Llc, Dir of Scribe Therapeutics, Inc. (SCTX), bought 1,000,000 shares of SCTX stock worth $15M, per an SEC Form 4 filed Jul 29, 2026.

The shares came through a private deal, not the open market.

The trade happened on Jul 27, 2026, 2 days before it was made public.

SCTX has moved +47.9% since the trade date, from $18.97 to $28.05 (Sep 21, 2026 close).